105 related articles for article (PubMed ID: 2370552)
1. In vivo autoxidation of dopamine in guinea pig striatum increases with age.
Fornstedt B; Pileblad E; Carlsson A
J Neurochem; 1990 Aug; 55(2):655-9. PubMed ID: 2370552
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
Fornstedt B; Carlsson A
Neuropharmacology; 1991 May; 30(5):463-8. PubMed ID: 1907723
[TBL] [Abstract][Full Text] [Related]
3. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment.
Fornstedt B; Carlsson A
J Neural Transm; 1989; 76(2):155-61. PubMed ID: 2496196
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.
Fornstedt Wallin B
J Neural Transm (Vienna); 2024 Mar; 131(3):213-228. PubMed ID: 38238531
[TBL] [Abstract][Full Text] [Related]
5. Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum.
Fornstedt B; Carlsson A
J Neurochem; 1991 Feb; 56(2):407-14. PubMed ID: 1988547
[TBL] [Abstract][Full Text] [Related]
6. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
Fornstedt B; Bergh I; Rosengren E; Carlsson A
J Neurochem; 1990 Feb; 54(2):578-86. PubMed ID: 2105377
[TBL] [Abstract][Full Text] [Related]
7. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Spencer JP; Jenner P; Daniel SE; Lees AJ; Marsden DC; Halliwell B
J Neurochem; 1998 Nov; 71(5):2112-22. PubMed ID: 9798937
[TBL] [Abstract][Full Text] [Related]
8. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra.
Fornstedt B; Brun A; Rosengren E; Carlsson A
J Neural Transm Park Dis Dement Sect; 1989; 1(4):279-95. PubMed ID: 2597314
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
Fornstedt B; Rosengren E; Carlsson A
Neuropharmacology; 1986 Apr; 25(4):451-4. PubMed ID: 3086766
[TBL] [Abstract][Full Text] [Related]
10. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
11. Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson's disease.
Carlsson A; Fornstedt B
Neurology; 1991 May; 41(5 Suppl 2):50-1; discussion 52. PubMed ID: 2041593
[TBL] [Abstract][Full Text] [Related]
12. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
13. Sensitive high-performance liquid chromatographic method for the determination of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid and 5-S-cysteinyl-3,4-dihydroxyphenylalanine.
Fornstedt-Wallin B; Bergh I
J Chromatogr B Biomed Appl; 1995 Jan; 663(1):9-14. PubMed ID: 7704217
[TBL] [Abstract][Full Text] [Related]
14. Pheomelanin production by the lipoxygenase-catalyzed oxidation of 5-S-cysteinyldopa and 5-S-cysteinyldopamine.
Mosca L; Foppoli C; Coccia R; Rosei MA
Pigment Cell Res; 1996 Jun; 9(3):117-25. PubMed ID: 8888310
[TBL] [Abstract][Full Text] [Related]
15. Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease.
Shen XM; Dryhurst G
Chem Res Toxicol; 1996 Jun; 9(4):751-63. PubMed ID: 8831820
[TBL] [Abstract][Full Text] [Related]
16. Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.
Goldstein DS; Holmes C; Sullivan P; Jinsmaa Y; Kopin IJ; Sharabi Y
Parkinsonism Relat Disord; 2016 Oct; 31():79-86. PubMed ID: 27474472
[TBL] [Abstract][Full Text] [Related]
17. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
Xu K; Dluzen DE
J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
[TBL] [Abstract][Full Text] [Related]
18. Transformation of dopamine and alpha-methyldopamine by NG108-15 cells: formation of thiol adducts.
Patel N; Kumagai Y; Unger SE; Fukuto JM; Cho AK
Chem Res Toxicol; 1991; 4(4):421-6. PubMed ID: 1912328
[TBL] [Abstract][Full Text] [Related]
19. Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum.
Kaakkola S; Wurtman RJ
J Neurochem; 1993 Jan; 60(1):137-44. PubMed ID: 8417137
[TBL] [Abstract][Full Text] [Related]
20. 5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons.
Spencer JP; Whiteman M; Jenner P; Halliwell B
J Neurochem; 2002 Apr; 81(1):122-9. PubMed ID: 12067224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
